New shot in the eye aims to halt leading cause of blindness
NCT ID NCT07406438
Summary
This is an early-stage study testing a new medication called GB10, which is injected into the eye. It aims to see if GB10 is safe and can help control 'wet' age-related macular degeneration (AMD), a major cause of vision loss. The study will test different doses in up to 48 people who have this condition, to find the best balance of safety and effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tongren Hospital, Capital Medical University
Beijing, Beijing Municipality, 100730, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Henan Provincial Eye Hospital
Zhengzhou, Henan, 450015, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Nanchang University Second Affiliated Hospital
Nanchang, Jiangxi, 330006, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Sir Run Run Shaw Hospital (SRRSH), affiliated with Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310016, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Affiliated Hospital of Guizhou Medical University
Guiyang, Guizhou, 550004, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, 310014, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.